Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Significant treatment failure with intravitreous bevacizumab for retinopathy of prematurity.

× No keyword cloud information.

24 in total

Review 1. Pharmacologic interventions for the prevention and treatment of retinopathy of prematurity.

Authors: Kay D Beharry; Gloria B Valencia; Douglas R Lazzaro; Jacob V Aranda
Journal: Semin Perinatol Date: 2016-01-29 Impact factor: 3.300

2. Intravitreal injection of bevacizumab for retinopathy of prematurity.

Authors: Kazuki Kuniyoshi; Koji Sugioka; Hiroyuki Sakuramoto; Shunji Kusaka; Norihisa Wada; Yoshikazu Shimomura
Journal: Jpn J Ophthalmol Date: 2014-02-26 Impact factor: 2.447

3. Clinical Management of Recurrent Retinopathy of Prematurity after Intravitreal Bevacizumab Monotherapy.

Authors: Helen A Mintz-Hittner; Megan M Geloneck; Alice Z Chuang
Journal: Ophthalmology Date: 2016-05-27 Impact factor: 12.079

Review 4. Vascular endothelial growth factor antagonist therapy for retinopathy of prematurity.

Authors: M Elizabeth Hartnett
Journal: Clin Perinatol Date: 2014-09-23 Impact factor: 3.430

Review 5. Pathophysiology and mechanisms of severe retinopathy of prematurity.

Authors: M Elizabeth Hartnett
Journal: Ophthalmology Date: 2014-10-14 Impact factor: 12.079

6. Anti-VEGF antibody leads to later atypical intravitreous neovascularization and activation of angiogenic pathways in a rat model of retinopathy of prematurity.

Authors: Manabu McCloskey; Haibo Wang; Yanchao Jiang; George Wesley Smith; Jeremy Strange; M Elizabeth Hartnett
Journal: Invest Ophthalmol Vis Sci Date: 2013-03-21 Impact factor: 4.799

7. Targeting Müller cell-derived VEGF164 to reduce intravitreal neovascularization in the rat model of retinopathy of prematurity.

Authors: Yanchao Jiang; Haibo Wang; David Culp; Zhihong Yang; Lori Fotheringham; John Flannery; Scott Hammond; Tal Kafri; M Elizabeth Hartnett
Journal: Invest Ophthalmol Vis Sci Date: 2014-02-10 Impact factor: 4.799

8. Reactivation of Retinopathy of Prematurity in Adults and Adolescents.

Authors: Ogul E Uner; Prethy Rao; G Baker Hubbard
Journal: Ophthalmol Retina Date: 2020-02-11

9. Hyperoxia causes regression of vitreous neovascularization by downregulating VEGF/VEGFR2 pathway.

Authors: Hua Liu; Wenbo Zhang; Zhimin Xu; Robert W Caldwell; Ruth B Caldwell; Steven E Brooks
Journal: Invest Ophthalmol Vis Sci Date: 2013-02-01 Impact factor: 4.799

10. The results of intravitreal bevacizumab monotherapy for treating aggressive posterior retinopathy of prematurity and Type 1 retinopathy of prematurity.

Authors: Ayşegül Çömez; Yalçın Karaküçük; Mehmet Cüneyt Özmen; Pelin Çelemler; Oğuzhan Saygılı
Journal: Eye (Lond) Date: 2021-01-29 Impact factor: 3.775